Page last updated: 2024-11-06

flazasulfuron

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Flazasulfuron is a sulfonylurea herbicide used for post-emergent weed control in various crops, including rice, wheat, and sugarcane. It inhibits acetolactate synthase (ALS), an enzyme essential for amino acid biosynthesis in plants, leading to growth inhibition and eventual death. Flazasulfuron is highly effective against broadleaf weeds and some grasses, including resistant biotypes. Its synthesis involves multiple steps starting from readily available chemicals and involves reactions such as sulfonylation, amidation, and ring closure. Flazasulfuron is studied for its potential to control weeds in specific crops and to understand its effects on non-target organisms and the environment. Its mode of action and its effectiveness against resistant weeds make it a valuable herbicide, but its environmental impact needs to be carefully monitored and mitigated.'

flazasulfuron: vineyard herbicide in freshwater algae; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93539
CHEMBL ID1878071
CHEBI ID81749
SCHEMBL ID54678
MeSH IDM0453603

Synonyms (37)

Synonym
sl-160
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
ok-1166
shibagen [japanese]
n-(((4,6-dimethoxy-2-pyrimidinyl)amino)carbonyl)-3-(trifluoromethyl)-2-pyridinesulfonamide
2-pyridinesulfonamide, n-(((4,6-dimethoxy-2-pyrimidinyl)amino)carbonyl)-3-(trifluoromethyl)-
flazasulfuron [iso]
flazasulfuron
NCGC00164266-01
1-(4,6-dimethoxypyrimidin-2-yl)-3-[3-(trifluoromethyl)pyridin-2-yl]sulfonylurea
104040-78-0
1-(4,6-dimethoxy-2-pyrimidinyl)-3-[[3-(trifluoromethyl)-2-pyridinyl]sulfonyl]urea
A800883
C18441
shibagen
3sb13wwv30 ,
hsdb 7957
unii-3sb13wwv30
FT-0642552
n-(4,6-dimethoxy-2-pyrimidinylaminocarbonyl)-3-(trifluoromethyl)-2-pyridinesulfonamide
AKOS015900343
flazasulfuron [mi]
katana
SCHEMBL54678
CHEBI:81749 ,
CHEMBL1878071
DTXSID3034610
J-001097
flazasulfuron, pestanal(r), analytical standard
HWATZEJQIXKWQS-UHFFFAOYSA-N ,
Q3073504
flazasulfuron;1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
F21476
flazasulfuron 100 microg/ml in acetonitrile
n-(4,6-dimethoxypyrimidin-2-ylcarbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide
CS-0440149
n-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)-3-(trifluoromethyl)pyridine-2-sulfonamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.00000.000229.305416,493.5996AID588513
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00140.023723.228263.5986AID588543
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.07080.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's3 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.93 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index68.41 (26.88)
Search Engine Supply Index3.97 (0.95)

This Compound (30.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]